Author: healthadmin

Recent research published in journals Psychology of popular media It suggests how problematic social media use changes the relationship between our sense of personal and national freedom and mental health. The findings show that while feeling free generally supports improved psychological well-being, an unhealthy obsession with social media tends to weaken the benefits of personal freedom while reinforcing the positive effects of national pride. Psychologists generally agree that feeling free leads to improved mental health. The concept of freedom in psychology is broad. It involves a clear sense of personal freedom as well as a sense of belonging to a…

Read More

Tyrannosaurus rex is usually depicted as a powerful and merciless predator. But they also took advantage of the opportunity to scavenge, according to a new study. When food was available, they did not hesitate to eat the carcasses of animals, down to the last scraps. The findings come from a study by Aarhus University’s Department of Geosciences, which was recently published in the journal. evolving earth. Traces of cannibalism revealed from fossilized bite marks The research was led by Josephine Nielsen, a master’s student in geosciences. She used advanced 3D scanning technology to examine the fossilized metatarsals (foot bones) of…

Read More

Novartis continues its multi-year review with new plans to close its production facility in Wehr, Germany. Novartis said the measures announced Tuesday will result in the elimination of about 220 jobs. The Swiss drugmaker expects the site to be shut down by the end of 2028. The Wehr facility primarily focuses on older medicines from Novartis’ portfolio and utilizes traditional solid oral dosage forms such as tablets and capsules. The company said the planned closure of the Wehr plant will not affect Novartis’ drug supply. Novartis’ latest manufacturing restructuring marks a new shift from older technologies to high-growth modalities. The…

Read More

You’re reading the web version of DC Diagnosis, STAT’s twice-weekly newsletter on health and medical politics and policy. Sign up here to get it in your inbox on Tuesdays and Thursdays. “Healthcare (sic),” Blaine Reid, who writes a newsletter on drug pricing policy, wrote in Friday’s edition. I feel very stupid to laugh at that “chic” notation. Share your thoughts on AP’s new compound noun words here and send your news tips to: (email protected) Or Signal’s John_Wilkerson.07. CPT codes become the new front line for fraud allegations House Oversight Committee Chairman James Comer (R-Ky.) has taken aim at the…

Read More

Written by Ben Felder, Midwest Survey, Midwest Survey May 5, 2026 Last summer, 18 different pesticide compounds were detected in 10 parks and playgrounds across Illinois, including pesticides that washed ashore at least 3,700 feet from the nearest application site. The new study, conducted by the Champaign-based nonprofit Prairie Rivers Network, comes days after a state bill that would have required pesticide applicators to notify nearby schools and parks before spraying was defeated. “There was pretty strong opposition from the agricultural industry,” said Kim Erndt Pitcher, environmental health director for Prairie Rivers Network, referring to House Bill 1596. “But we…

Read More

Kyverna Therapeutics is taking a historic first step in approving a CAR-T therapy for an autoimmune disease. And now we’re getting closer to the finish line and trying to make even more commercial impact. The California-based biotech company has hired Omeros and AbbVie alumnus Nadia Duck as its new chief commercial officer, who will “lead commercial strategy and execution for miv-cel (mivocabtagene autoreucel),” according to a May 4 statement. The therapy recently produced positive results in a registration trial for stiff person syndrome (SPS), putting it on track to become the first CAR-T therapy approved for an autoimmune disease, after…

Read More

Recent research published in journals nature communications Our results suggest that a single high dose of psilocybin can cause lasting changes in human brain connectivity and psychological well-being. Scientists found that these brain changes, with evidence of increased mental flexibility and insight, persisted for at least a month after the experience. This study provides a rare glimpse into the biological and psychological changes that occur when a person takes a psychedelic substance for the first time. Psilocybin is the main psychoactive compound found in certain types of mushrooms. When a person ingests this substance, the body converts it to psilocin.…

Read More

A meta-analysis of studies involving more than 3.2 million participants found that major depressive disorder was significantly more prevalent among patients with cannabis use disorder compared to the general population, and vice versa. In a psychiatric sample of individuals with cannabis use disorder, 19% also had current major depressive disorder. This proportion was 22% in the community sample. The paper was published in. Psychiatric Research Journal. Depression, or major depressive disorder, is one of the most prevalent mental health conditions worldwide. According to recent data, approximately 13% of people have been diagnosed with depression at least once in their life.…

Read More

New research published in Journal of Sex Research Evidence shows that when teenage daughters talk humorously about sex with their mothers, they tend to have better sexual well-being. The same study suggests that when mothers use humor during conversations, it can actually make daughters less willing to open up. These findings reveal how how families interact during sensitive discussions shapes healthy sexual development in teenagers. Discussing sexuality is often an uncomfortable experience for both parents and teens. Student and educational consultant Rotem Shumil Itzhak and Professor Yaniv Efrati, head of the Addictive Behaviors Laboratory at the Faculty of Education at…

Read More

Although largely in the background until recently, Prolific Machines’ optogenetic approach to biomanufacturing is about to make a splash with the company achieving an impressive milestone in monoclonal antibody (mAb) production. Now, in addition to a recent new technology designation from the FDA and increased interest in its platform from industry heavyweights, Prolific is increasingly well-positioned as its light-controlled production methods come into the spotlight. Prolific announced that it has reached a record-breaking productivity milestone of 21 g/L in a 15-day enriched fed-batch Chinese hamster ovary (CHO) cell line run of mAbs, leveraging a custom-built Photomolecular platform designed to “directly…

Read More